J & J Approaches Swiss Firm Actelion About Potential Deal

Johnson& Johnson has approached Swiss biopharmaceutical company Actelion about a possible deal, the two companies said Friday.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news
More News: Pharmaceuticals